GSK Investigational Site

Laval, Quebec H7V 2T8

0 studies enrolling now · 16 studies all time

What they study most

Diabetes Mellitus, Diabetes Mellitus, Type 2, Dyslipidaemias, Nausea, Nausea and Vomiting, Chemotherapy-Induced, Neoplasms, Breast, Neoplasms, Prostate, Purpura, Thrombocytopaenic, Idiopathic, Vomiting

Studies at this site

Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus — Completed
Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes Subjects — Completed
A Study To Evaluate The Safety And Efficacy Of An Investigational Diabetes Drug In Poorly Controlled Type II Diabetics — Completed
A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting. — Completed
Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide — Completed
ARI103094-Follow-Up Study for REDUCE Study Subjects — Completed
RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag — Completed
Thiazolidinedione Intervention With Vitamin D Evaluation — Stopped early
Study In People With Type 2 Diabetes — Completed
Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy — Completed
Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men — Completed
"REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk — Completed
Rosiglitazone on Microalbuminuria in Type 2 Diabetics — Completed
Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer — Completed
Dyslipidemia Study Investigating The Increase In "Good Cholesterol" — Completed
Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting — Completed